Stefan Schmelz
Braunschweig, NI, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Highly potent quinoxalinediones inhibit α-hemolysin and ameliorate Staphylococcus aureus lung infections.
Journal: Cell host & microbe
Published: August 23, 2024
Discovery and optimization of thiazole-based quorum sensing inhibitors as potent blockers of Pseudomonas aeruginosa pathogenicity.
Journal: European journal of medicinal chemistry
Published: April 07, 2024
Reverse mutational scanning of SARS-CoV-2 spike BA.2.86 identifies epitopes contributing to immune escape from polyclonal sera.
Journal: Nature communications
Published: January 11, 2024
The Cytomegalovirus M35 Protein Directly Binds to the Interferon-β Enhancer and Modulates Transcription of Ifnb1 and Other IRF3-Driven Genes.
Journal: Journal of virology
Published: June 08, 2023
Role of Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 in Inflammation and Pathogen-Associated Interactions.
Journal: Journal of innate immunity
Published: June 01, 2023
Towards Translation of PqsR Inverse Agonists: From In Vitro Efficacy Optimization to In Vivo Proof-of-Principle.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: August 03, 2022
Reproducible and Easy Production of Mammalian Proteins by Transient Gene Expression in High Five Insect Cells.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: May 05, 2021
Divergent synthesis and biological evaluation of 2-(trifluoromethyl)pyridines as virulence-attenuating inverse agonists targeting PqsR.
Journal: European journal of medicinal chemistry
Published: March 25, 2021
Last Updated: 09/26/2026